Nuria Quesada García

New recommendations from the 2024 ESC Guidelines on CCS for INOCA/ANOCA 🔝. @secardiologia @shci_sec @JEscaned @ramonlopezpalop @fer_iver @belcid7 @ErnestoValero84 🥇Coronary función test (CFT) to identify INOCA/ANOCA endotypes: IB 🥈Medical treatment guided by CFT: IIa. 🥉Angina in HFpEF with unobstructred CAD, rule out MVD: IIa. 🎯Definition of endotypes and Specific treatment recommendations

"Intracoronary imaging guidance by IVUS or OCT is recommended for performing PCI on anatomically complex lesions, in particular left main stem, true bifurcations and long lesions. " EHJ2024 @OctoberTrial @h_evald @GreggWStone @LNAndreasen @ziadalinyc @DrPeterOKane @omeedneghabat @twj1974 @DrKoltowski @mmamas1973 @BURZOTTA_F @dukwoo_park @jcspratt @SimoneBiscaglia @GianlucaCampo78 #imagingfirst #cardiotwitter #ESCcongress2024

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

⚡️Big News w/ #ESCGuidelines OCT-guided PCI & assessing patients for CMD now @ Class 1A & 1B Abbott leads the way w/ unique solutions to improve patient outcomes AI-driven #Ultreon for OCT PressureWire X & CoroFlow for INOCA/ANOCA patients Safety Info: bit.ly/3T8XwRn

🚨Breaking News: New ESC Guidelines on CCS. Intracoronary Imaging now Class IA for LM, true bifurcation and long lesions! Either OCT or IVUS. @PCRonline @escardio @NielsRHolm @twj1974 @nicolasamabile @FBiccire @ziadalinyc @hect2701 @sbrugaletta @HolgerNef

Happening NOW in the #EuroPCR Training Village. Great to see physicians honing their skills with our AI-driven #IntravascularImaging and exploring the features of our orbital atherectomy technology. #CardioTwitter

Large network meta-analysis shared in @theLancet bit.ly/4bPbFuP showed for the first time reductions in clinical events demonstrating safety & effectiveness of image-guided PCI ⬇️25% all-cause death ⬇️17% MI ⬇️48% ST ⬇️28% repeat TVR Safety Info: bit.ly/ISI_info

📰 Late-breaking data at #CRT2024: XIENCE #Stent showed strong performance in patients with single-layer ISR at 1-year: ¹ • 0% cardiac death  • 0.4% all cause death  • 1.2% ST    Learn more & safety Info: cardiovascular.abbott/us/en/hcp/prod…

This 👇

Returning from Barcelona, where we have enjoyed a great course on #MINOCA, masterfully conducted by @josepgomezlara & @egutiMD, with the engaging @twj1974 #FernandoAlfonso @sbrugaletta @javierlopezpais @Dra_IzdoCoronel and other great speakers

Join us during ACI 2024 in London on 1/31 from 6-8pm at the Hilton Metropole London, UL. Discover the future of cardiac care with HeartFlow’s interactive session on CCTA+FFRCT at BCIS ACI 2024. Register here: bit.ly/3HvCVR4. @NickCurzen @ColletCarlos @BCIS_uk

I curso de Calcio-OCT en HJRJ, Huelva. La formación, la base para abordar las lesiones coronarias mas complejas guiadas por OCT, buscando la excelencia con grandes AMIGOS EXPERTOS. @cardiojsl @AJuradoRoman @CamachoFreire @ElenaIzaga @OscarLa81605851 @Albabfc

Aun quedan plazas libres para asistir al curso de MINOCA el 2/2/24 en BCN. Expertos nacionales e internacionales nos mostraran los algoritmos diagnosticos para este dx de trabajo y sus causas con la presentacion de 6 casos clinicos. No te lo pierdas! Link: secardiologia.es/agenda/2877-ad…

Get a demo of our latest Ultreon 2.0 Software for #OCTimaging at #TCT2023 at Abbott’s booth. ➡️ Sign up to get more info: bit.ly/46oyh1x #imagefirst Safety Info: bit.ly/3mHYQvh

From the latest #OCTimaging clinical data at #ESC2023 to the latest imaging solution—Ultreon 2.0 Software, our AI-enabled IVI software. 3⃣top reasons why you should consider Ultreon Software for your complex PCI. #imagefirst Safety Info: bit.ly/3mHYQvh 1/5

It’s finally OCT-ober 🎃 our special time of the year to highlight 🔑 info about #OCTimaging 💡 for PCI guidance. This year there’s a lot of new of imaging data post #ESC2023. So let’s dive in, #CardioTwitter. ⬇️ Safety Info: bit.ly/OCT_ISI 🧵 1/8

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided #PCI ⬇️ #ESCCongress ILUMIEN IV trial

Optical coherence tomography (#OCT) is non-inferior to intravascular ultrasound (#IVUS) for guiding percutaneous coronary intervention (#PCI) ⬇️ #ESCCongress OCTIVUS trial

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided #PCI ⬇️ #ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis

Percutaneous coronary intervention (#PCI) guided by optical coherence tomography (#OCT) reduces adverse cardiac events in patients with bifurcation lesions ⬇️ #ESCCongress OCTOBER trial